Malaga Cove Capital’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-52,276
Closed -$2.23M 162
2019
Q1
$2.23M Sell
52,276
-1,618
-3% -$72.4K 1.36% 14
2018
Q4
$2.39M Sell
53,894
-806
-1% -$42.2K 1.65% 12
2018
Q3
$3.72M Sell
54,700
-994
-2% -$64K 2.02% 6
2018
Q2
$3.19M Sell
55,694
-657
-1% -$34.7K 1.61% 15
2018
Q1
$2.6M Sell
56,351
-80
-0.1% -$3.8K 1.4% 21
2017
Q4
$2.61M Sell
56,431
-329
-0.6% -$15.1K 1.46% 20
2017
Q3
$2.6M Hold
56,760
1.49% 18
2017
Q2
$2.24M Buy
56,760
+568
+1% +$21.5K 1.34% 22
2017
Q1
$2.12M Buy
56,192
+15,188
+37% +$592K 1.29% 27
2016
Q4
$1.52M Sell
41,004
-448
-1% -$16K 1% 34
2016
Q3
$1.42M Buy
+41,452
New +$1.45M 1.02% 31

Other funds holding AVNS

Malaga Cove Capital's AVNS Position: Q2 2019 in Review

Malaga Cove Capital sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 52,276 shares — an estimated $2.23M sold.

Malaga Cove Capital first reported a position in AVNS in Q3 2016 and held it in 11 quarters. The position peaked at $3.72M in Q3 2018. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

  • Malaga Cove Capital reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
  • Malaga Cove Capital sold 52,276 Avanos Medical shares in Q2 2019, an estimated $2.23M.
  • Malaga Cove Capital first reported a position in Avanos Medical in Q3 2016 and held it in 11 quarters.
  • Malaga Cove Capital's Avanos Medical position peaked at $3.72M in Q3 2018.
  • 317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Malaga Cove Capital's 13F filing for Q2 2019, filed 14 Aug 2019.